Cited by 66Parkinson's Disease Mechanisms and TreatmentsNitric Oxide and Endothelin EffectsNuclear Receptors and Signaling

Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat

Open access
Barthwal, M.K., Srivastava, N., Dikshit, M.·2001·Redox Report

Abstract

This study was undertaken to investigate the nitric oxide synthase (NOS) activity in the striatum following 6-hydroxydopamine (6-OHDA) induced neurodegeneration in rats. Constitutive NOS (cNOS) activity remained unaltered at 3, 7 and 14 days after lesion, while a 43% and 45% decrease was observed at 30 and 50 days, respectively. Inducible NOS (iNOS) activity was detected only on the 3rd day after lesion and not in subsequent days or the control striatum. N(G)-nitro-L-arginine methyl ester (L-NAME) pretreatment blocked the amphetamine-induced rotations and inhibited the iNOS activity at the 3rd day after the 6-OHDA injection. L-NAME pretreatment also significantly restored the striatal dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels in 6-OHDA treated rats. Thus a possible role of nitric oxide in 6-OHDA induced neurodegeneration is suggested.

Integrity signals

Registry

Crossref · 10.1179/135100001101536436

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Barthwal, M. K., Srivastava, N., & Dikshit, M.
Affiliations
Central Drug Research Institute (IN)
Venue
Redox Report
Published
2001-10
Volume
6
Issue
5
Pages
297-302
ISSN
  • 1351-0002 (ISSN-L)
  • 1743-2928
OpenAlex
W2008520631
Cited by
66
References
1
Citations by year
2024: 2 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
0.93
Type
journal article
Language
en
Open access
Locations
  • Redox Report (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
nitric oxide, Parkinson's disease, 6-hydroxydopamine, neurodegeneration, inducible nitric oxide synthase, constitutive nitric oxide synthase, striatum, L-NAME, dopamine, DOPAC, homovanillic acid, amphetamine-induced rotation, neuroprotection
MeSH terms
Animals, Corpus Striatum, Disease Models, Animal, Dopamine, Enzyme Inhibitors, Homovanillic Acid, Male, Motor Activity, Nitric Oxide, Parkinson Disease, Parkinson Disease, Secondary, 3,4-Dihydroxyphenylacetic Acid, Oxidopamine, Rats, Sprague-Dawley, Disease Progression, Adrenergic Agents, Nitric Oxide Synthase, NG-Nitroarginine Methyl Ester, Rats, Nitric Oxide Synthase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review